tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (CSSPF)
OTHER OTC:CSSPF
US Market
Advertisement

Circassia Pharmaceuticals (CSSPF) Ratios

Compare
8 Followers

Circassia Pharmaceuticals Ratios

CSSPF's free cash flow for Q2 2025 was £0.62. For the 2025 fiscal year, CSSPF's free cash flow was decreased by £ and operating cash flow was £0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 19Dec 18Dec 17
Liquidity Ratios
Current Ratio
3.73 1.17---
Quick Ratio
3.07 1.01---
Cash Ratio
1.97 0.65---
Solvency Ratio
1.42 -0.03---
Operating Cash Flow Ratio
3.12 -0.61---
Short-Term Operating Cash Flow Coverage
31.17 0.00---
Net Current Asset Value
£ 15.80M£ -113.70M---
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.45---
Debt-to-Equity Ratio
0.02 1.31---
Debt-to-Capital Ratio
0.02 0.57---
Long-Term Debt-to-Capital Ratio
0.00 0.56---
Financial Leverage Ratio
1.10 2.91---
Debt Service Coverage Ratio
11.63 -229.00---
Interest Coverage Ratio
46.50 -185.00---
Debt to Market Cap
<0.01 0.02---
Interest Debt Per Share
<0.01 0.30---
Net Debt to EBITDA
-0.77 -6.98---
Profitability Margins
Gross Profit Margin
61.96%73.70%---
EBIT Margin
20.65%-79.48%---
EBITDA Margin
29.78%-34.97%---
Operating Profit Margin
20.22%-53.47%---
Pretax Profit Margin
20.22%-79.77%---
Net Profit Margin
11.30%-48.55%---
Continuous Operations Profit Margin
10.65%-48.55%---
Net Income Per EBT
55.91%60.87%---
EBT Per EBIT
100.00%149.19%---
Return on Assets (ROA)
7.32%-6.81%---
Return on Equity (ROE)
8.39%-19.81%---
Return on Capital Employed (ROCE)
14.31%-9.00%---
Return on Invested Capital (ROIC)
7.47%-12.49%---
Return on Tangible Assets
12.18%-21.27%---
Earnings Yield
1.85%-0.24%---
Efficiency Ratios
Receivables Turnover
6.97 2.34---
Payables Turnover
15.91 1.00---
Inventory Turnover
4.38 1.40---
Fixed Asset Turnover
30.67 14.42---
Asset Turnover
0.65 0.14---
Working Capital Turnover Ratio
3.13 -1.09---
Cash Conversion Cycle
112.86 51.84---
Days of Sales Outstanding
52.37 156.13---
Days of Inventory Outstanding
83.43 260.71---
Days of Payables Outstanding
22.94 365.00---
Operating Cycle
135.80 416.84---
Cash Flow Ratios
Operating Cash Flow Per Share
0.05 -0.07---
Free Cash Flow Per Share
0.05 -0.07---
CapEx Per Share
<0.01 <0.01---
Free Cash Flow to Operating Cash Flow
1.01 1.01---
Dividend Paid and CapEx Coverage Ratio
3.67 -83.67---
Capital Expenditure Coverage Ratio
187.00 -83.67---
Operating Cash Flow Coverage Ratio
15.58 -0.23---
Operating Cash Flow to Sales Ratio
0.41 -0.73---
Free Cash Flow Yield
6.60%-0.36%---
Valuation Ratios
Price-to-Earnings (P/E) Ratio
53.95 -422.64---
Price-to-Sales (P/S) Ratio
6.20 205.21---
Price-to-Book (P/B) Ratio
4.36 83.73---
Price-to-Free Cash Flow (P/FCF) Ratio
15.16 -279.54---
Price-to-Operating Cash Flow Ratio
15.00 -282.88---
Price-to-Earnings Growth (PEG) Ratio
0.93 6.23---
Price-to-Fair Value
4.36 83.73---
Enterprise Value Multiple
20.03 -593.78---
Enterprise Value
274.39M 7.18B---
EV to EBITDA
20.03 -593.78---
EV to Sales
5.97 207.65---
EV to Free Cash Flow
14.60 -282.86---
EV to Operating Cash Flow
14.67 -286.25---
Tangible Book Value Per Share
0.09 -0.22---
Shareholders’ Equity Per Share
0.16 0.23---
Tax and Other Ratios
Effective Tax Rate
0.47 -0.39---
Revenue Per Share
0.11 0.09---
Net Income Per Share
0.01 -0.04---
Tax Burden
0.56 0.61---
Interest Burden
0.98 1.00---
Research & Development to Revenue
0.05 1.48---
SG&A to Revenue
0.10 0.36---
Stock-Based Compensation to Revenue
0.00 0.04---
Income Quality
3.82 0.52---
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis